Four people working around a desk

Service Pathway Review

Benchmarking your service against best practice to improve your pathways

We work with commissioners to review healthcare interventions and clinical pathways to understand what works well and where improvements could be made so that services are better for patients.

What we do

  • We review capacity including workforce, equipment and clinic slots in order to identify pinch points where changes would be beneficial
  • We identify and recommend models of service delivery and best practice and map existing provision against this
  • We synthesise evidence from research, data and clinical opinion to inform the re-design process so that pathways can be more efficient
  • We identify what works in other areas and facilitate discussion through engagement events to identify what would work for both the provider and commissioner to improve service quality
  • We make evidence-based recommendations as to how to improve pathways for the benefit of patients

Why choose SPH?

We offer a combination of expertise in both the theory and practical application of change management and service redesign, embedded in a thorough understanding of the NHS. This is strengthened by strong clinical knowledge and experience. Please get in touch via our contact page.

Case Studies

Improving allocative value decision-making in the stroke pathway (STAR tool)

The Mid and South Essex stroke stewardship group wanted to better understand which of the interventions they delivered were high value and which were low value to inform decision-making on use of resources and investment. Arden & GEM’s Healthcare Solutions team provided training and support to enable the group to use the Socio-Technical Allocation of Resources (STAR) process in value based decision-making. As a result, the MSE stroke stewardship group has the insight needed to improve the allocation of their existing resources and improve outcomes for their patients. SPH were part of the project team, conducting a librarian review of economic evidence relating to cost-effectiveness of the stroke interventions to feed into the first workshop. This comprised a review of existing economic cost-effectiveness assessments (ideally by NICE as these are recognised as the guiding authority within the NHS). Where an economic assessment had not been undertaken then this was noted for further consideration. More detail here
Testimonials